| Jun 5 |
Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit
|
| May 31 |
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
|
| May 30 |
Sharps Technology jumps on $200M sales agreement for syringes with Nephron Pharma
|
| May 30 |
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
|
| May 29 |
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
|
| May 28 |
Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes
|
